Switched to TeleMed at 0.6 mg SC daily for Liraglutide; monthly out-of-pocket dropped to $184.80 compared with $589.00 retail.
Liraglutide
Brand Reference: Victoza, Saxenda
Liraglutide Clinical & Real-World Cost Fact Matrix
| Metric | Verified Benchmark | Source |
|---|---|---|
| Liraglutide RxNorm Concept ID | 475968 | U.S. National Library of Medicine (RxNorm) |
| CMS NADAC Pharmacy Acquisition Unit Cost | $18.6400 / unit | CMS Medicaid NADAC Weekly Feed |
| Walk-In Chain Pharmacy Cash Average | $589.00 / mo | CMS NADAC + U.S. Retail Markup Index |
| Mark Cuban Cost Plus Wholesale Price | $165.00 / mo (Direct TeleMed) | Direct Telehealth Formulary |
| Community Mean Out-of-Pocket Paid | $210.00 / mo | 16 Zero-PHI Verified Patient Logs |
Verified Online Prescribers & Wholesale Pharmacies for Liraglutide
Liraglutide Clinical Pharmacology & DailyMed Monograph
RxCUI 475968 • NDC 00169-4060-13Palmitoyl-acylated GLP-1 analogue that reversibly binds plasma albumin to resist DPP-4 degradation, activating cyclic AMP via Gs-coupled GLP-1 receptors on pancreatic beta cells and paraventricular hypothalamic satiety neurons.
CMS National Average Drug Acquisition Cost (NADAC) tracking places Liraglutide (Victoza / Saxenda, RxCUI 475968) at $18.6400 per unit, whereas walk-in chain pharmacies bill cash patients an average of $589.00 monthly—creating a 64% ($379.00/mo) wholesale arbitrage spread down to $210.00.
Systemic exposure to Liraglutide reflects 55% subcutaneous absorption kinetics and ubiquitous endopeptidase cleavage without single-organ predominance, sustaining receptor engagement across a 13 hours half-life window (8–12 hours to cmax response profile).
Dosing protocols (0.6 mg SC daily or 1.2 mg SC daily or 1.8 mg SC daily or 3.0 mg SC daily) balance efficacy (78.20% patient satisfaction across 16 logs) against nausea (38% of reports), diarrhea (17% of reports), dyspepsia (14% of reports), with strict avoidance in medullary thyroid carcinoma; men 2; pregnancy during weight-management dosing.
Standard Adult Titration & Dosages
Absolute & Relative Contraindications
- Medullary thyroid carcinoma
- MEN 2
- Pregnancy during weight-management dosing
Logged Side-Effect Incidence (16 Reports)
Liraglutide Patient Dosage Logs & Out-of-Pocket Cost Ledger
Across 16 verified cash-pay logs, Liraglutide achieves a 78.20% Worth-It rating with out-of-pocket spend averaging $210.00/mo versus $589.00/mo walk-in retail.
Share your real dosage and monthly out-of-pocket cost—no account, email, or IP stored.
Completed 10 weeks on Liraglutide (1.2 mg SC daily). Zero notable side effects on steady dosing.
Consistent biomarker response on 1.8 mg SC daily Liraglutide sourced via Cash Clinic ($243.60/mo cash pay without insurance prior authorization).